General Archive
-
Grand Challenges African Drug Discovery Accelerator programme: Supporting drug discovery projects in sub-Saharan Africa
Grand Challenges African Drug Discovery Accelerator programme: Supporting drug discovery projects in sub-Saharan Africa In collaboration with the Gates Foundation…
-
ReACT Africa: Tackling drug-resistant infections with ReACT Africa
Tackling drug-resistant infections with ReACT Africa In partnership with ReAct (Action on Antibiotic Resistance) Africa, we have launched ASPIRE, a…
-
News releasesNew £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
A new £6.2m healthcare project has begun in Kenya to advance elimination of visceral leishmaniasis, a deadly parasitic disease found…
-
iiCON and the Liverpool School of Tropical Medicine: A partnership tackling emerging viral threats and neglected tropical diseases
iiCON and the Liverpool School of Tropical Medicine: A partnership tackling emerging viral threats and neglected tropical diseases A £2.7…
-
Crick Africa Network: A partnership to support biomedical research in Africa
Crick Africa Network: A partnership to support biomedical research in Africa We have partnered with the Crick Africa Network (CAN)…
-
News releasesLifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership
The Crick Africa Network (CAN), a partnership between LifeArc, the Francis Crick Institute and 5 African institutions, has now awarded…
-
TB-MBLA: A test for both diagnosis and monitoring of tuberculosis over time
TB-MBLA: A test for both diagnosis and monitoring of tuberculosis over time We’ve partnered with the University of St Andrews…
-
News releasesReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
ReAct (Action on Antibiotic Resistance) Africa, in partnership with self-funded medical research organisation and charity LifeArc, is excited to introduce…
-
News releasesLifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa
LifeArc and the Bill & Melinda Gates Foundation are jointly investing £6 million ($7.2m) in the Grand Challenges African Drug…
-
News releasesNew UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance
A new UK-India research project, DOSA2, is trialling an easy-to-use test to determine if a urinary tract infection (UTI) is…
-
News releasesNew £30m initiative to address global threat by accelerating the pace of antimicrobial innovation
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10…
-
News releasesLifeArc welcomes Stéphane Maikovsky as Interim CEO
LifeArc, the self-funded, not-for-profit medical research organisation today announced the appointment of Stéphane Maikovsky as Interim Chief Executive Officer (CEO),…